ArticleJournal of orthopaedic surgery and research2026
Soft-tissue reconstruction timing in ballistic lower extremity open fractures: impact on osteomyelitis and union.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBallistic lower extremity open fractures represent a distinct subset of high-energy injuries characterized by extensive soft-tissue destruction, contamination, and complex wound biology. Although early soft-tissue reconstruction is widely advocated, a clinically relevant timing threshold specific to ballistic trauma remains unclear. This study aimed to evaluate the impact of soft-tissue reconstruction timing on osteomyelitis and bone union in ballistic lower extremity open fractures.
methodsThis retrospective cohort study included 56 adult male patients with high-energy ballistic lower extremity open fractures classified as Gustilo-Anderson type IIIB-IIIC, treated between 2016 and 2024. These injuries represent a severe form of extremity trauma, frequently encountered in military-related or complex trauma settings. Demographic characteristics, vascular injury, reconstruction timing, debridement burden, definitive fixation method, and clinical outcomes were recorded. Patients were stratified according to reconstruction timing. Receiver operating characteristic (ROC) analysis was performed to determine the optimal temporal threshold for predicting osteomyelitis, and logistic regression analysis was used to identify independent predictors.
resultsOsteomyelitis developed in 23 patients (41.1%). ROC analysis identified 14.5 days as the optimal threshold for soft-tissue reconstruction (AUC 0.773), with reconstruction beyond this cutoff significantly increasing osteomyelitis risk (58.8% vs. 13.6%). Multivariable logistic regression analysis demonstrated that increasing time to soft-tissue reconstruction was independently associated with osteomyelitis risk (OR 1.043 per day, p = 0.011). Bone union was achieved in 75% of patients, and no significant association was observed between reconstruction timing and time to union. Prolonged union was instead associated with a greater number of pre-reconstruction debridements.
conclusionDelayed soft-tissue reconstruction beyond approximately two weeks may be associated with an increased risk of osteomyelitis in ballistic lower extremity open fractures. These findings suggest that earlier provision of vascularized coverage, following adequate serial debridement, can be beneficial, while highlighting the importance of considering wound biology rather than relying solely on fixed temporal thresholds. Bone healing, in contrast, appears to be more closely related to initial injury severity than to reconstruction timing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.